Table 1.
Ref. | Age (yr) | Sex | Acinetobacter susceptibility | Final regimen(s) | Toxicity | Treatment outcome |
Kaplan et al[10] | 4 | NR | Multidrug resistant | Cefotaxime and aminoglycoside IV, and colistin IVR | None | Cure |
Ng et al[11] | 4 | Male | Multidrug resistant | Amikacin and colistin IV, and colistin IT | Chemical meningitis | Cure |
Ozdemir et al[12] | 3 | Female | Colistin | Colistin and ampicillin–sulbactam IV, and colistin IT | None | Cure |
14 | Female | Colistin | Meropenem and ampicillin–sulbactam IV, and rifampin PO | None | Cure | |
1 | Male | Colistin | Colistin and meropenem IV | None | Cure | |
Lee et al[13] | 3 | Male | Imipenem | Colistin IV | None | Cure |
Ganjeifar et al[14] | 6 | Male | Doxycycline and rifampin | Colistin and rifampin IV, and colistin IVR | NR | Cure |
Jiménez-Mejías et al[15] | 14 | Male | Colistin | Colistin IV | None | Cure |
IT: Intrathecal; IV: Intravenous; IVR: Intraventricular; PO: Peroral; NR: Not reported.